Allylamine

Allylamine

SCHEMBL253092

C=CCN.O=S(=O)(Cl)Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL270945 0.80
Sulfuric Acid SCHEMBL3951699 0.80 ALDH1A1 (0.60)
Allylamine SCHEMBL8725000 0.78
Sulfuric Acid SCHEMBL7072530 0.78 ALDH1A1 (0.56)
Allylamine SCHEMBL6032547 0.78
Allylamine SCHEMBL15197 0.78
Sulfuric Acid SCHEMBL6159499 0.78 ALDH1A1 (0.56)
Sulfuric Acid SCHEMBL7072523 0.78 ALDH1A1 (0.56)
Sulfuric Acid SCHEMBL7733310 0.78 ALDH1A1 (0.56)
Sulfamate SCHEMBL4760725 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088925-B2 low molecular weight factor Xa specific blood clotting inhibitors; less side effects; 5-Chloro-thiophene-2-carboxylic acid [2-(1-isopropyl-piperidin-4-ylsulfamoyl)-ethyl]-amide; thromboembolic diseases or restenosis; antithrombotic agents SANOFI-AVENTIS (FR) 2012-01-03 US disclosed
US-20080167346-A1 low molecular weight factor Xa specific blood clotting inhibitors; less side effects; 5-Chloro-thiophene-2-carboxylic acid [2-(1-isopropyl-piperidin-4-ylsulfamoyl)-ethyl]-amide; thromboembolic diseases or restenosis; antithrombotic agents SANOFI-AVENTIS (FR) 2008-07-10 US disclosed
CN-1258294-A 2-oxoimidazole derivs. BANYU PHARMA CO LTD (JP) 2000-06-28 CN disclosed